Is homocysteine a causal and treatable risk factor for vascular diseases of the brain (cognitive impairment and stroke)?

This publication has 42 references indexed in Scilit:

• Plasma Concentration of Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Is Elevated in Monkeys With Hyperhomocyst(e)inemia or Hypercholesterolemia
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• An alternative view of homocysteine
  The Lancet, 1999
• The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations
  New England Journal of Medicine, 1999
• White Matter Changes on CT and MRI: An Overview of Visual Rating Scales
  European Neurology, 1998
• A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin
  Annals of Neurology, 1997
• Pathogenesis of Leukoaraiosis
  Stroke, 1997
• Clinical Correlates of White Matter Findings on Cranial Magnetic Resonance Imaging of 3301 Elderly People
  Stroke, 1996
• Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study
  Neurology, 1994
• Cerebral white matter lesions and atherosclerosis in the Rotterdam Study
  The Lancet, 1993
• Hypertension in the elderly is associated with white matter lesions and cognitive decline
  Annals of Neurology, 1991